第80回日本血液学会学術集会

セッション情報

印刷

一般口演

Oral Session 2-9D Hemolytic anemia

2018年10月13日(土) 16:00 〜 17:00 第9会場 (大阪国際会議場 10F 1008)

Chair: Yukio Kondo (Department of Hematology, Kanawzawa University Hospital, Japan)

【Ｅ】

[OS2-9D-1] Safety and Efficacy of the Anti-C1s Antibody BIVV009 in Primary Cold Agglutinin Disease Patients

Ulrich Jaeger1, Shirley D'Sa2, Christian Schörgenhofer1, Johann Bartko1, Christian Sillaber1, Petra Jilma-Stohlawetz1, Michael Fillitz3, Thomas Schenk4, Gary Patou5, Sandip Panicker5, Graham C. Parry5, James C. Gilbert6, Bernd Jilma1 (1.Medical University of Vienna, Vienna, Republic of Austria, 2.University College London Hospitals NHS Foundation Trust & Mount Vernon Cancer Centre, London, United Kingdom of Great Britain and Northern Ireland, 3.Hanusch Krankenhaus, Vienna, Republic of Austria, 4.Universitätsklinikum St. Pölten, St. Pölten, Republic of Austria, 5.Bioverativ Therapeutics Inc., Waltham, United States of America, 6.True North Therapeutics, San Francisco, United States of America)

[OS2-9D-2] Coinherited biallelic mutation of SPTB and β-thalassemia trait causes severe hemolytic anemia

Pimlak Charoenkwan1, Chupong Ittiwut2,3, Rungrote Natesirinilkul1, Lalita Sathitsamitpong1, Arunee Phusua1, Kanda Fanhchaksai1, Supan Fucharoen4, Kanya Suphapeetiporn2,3, Vorasuk Shotelersuk2,3 (1.Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Muang, Kingdom of Thailand, 2.Department of Pediatrics, Faculty of Medicine, Center of Excellence for Medical Genomics, Chulalongkorn University, Pathumwan, Kingdom of Thailand, 3.Excellence Center for Medical Genetics, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Pathumwan, Kingdom of Thailand, 4.Centre for Research and Development of Medical Diagnostic Laboratories (CMDL), Faculty of Associated Medical Sciences, Khon Kaen University, Muang, Kingdom of Thailand)